Durable efficacy of selpercatinib in patients (pts) with medullary thyroid cancer (MTC): Update of the LIBRETTO-001 trial Meeting Abstract
| Authors: | Kroiss, M.; Sherman, E. J.; Wirth, L. J.; Cabanillas, M. E.; Robinson, B.; Subbiah, V.; Drilon, A. E.; Godbert, Y.; Fasnacht, N.; Soldatenkova, V.; Xia, M. S.; Duann, C. W.; Wright, J.; Weiler-Bisig, D.; Shah, M. |
| Abstract Title: | Durable efficacy of selpercatinib in patients (pts) with medullary thyroid cancer (MTC): Update of the LIBRETTO-001 trial |
| Meeting Title: | ESMO Congress 2022 |
| Journal Title: | Annals of Oncology |
| Volume: | 33 |
| Issue: | Suppl. 7 |
| Meeting Dates: | 2022 Sep 9-13 |
| Meeting Location: | Paris, France |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2022-09-01 |
| Start Page: | S1299 |
| End Page: | S1300 |
| Language: | English |
| ACCESSION: | WOS:000866211602208 |
| DOI: | 10.1016/j.annonc.2022.07.1736 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 1656P -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
